van Boven, J., Benhaddi, H., Roche, N., Bjermer, L., Miravitlles, M., Voorham, J., & Price, D. (2017). Real-world cost effectiveness comparison of symbicort turbuhaler and duoresp spiromax in UK patients with asthma or chronic obstructive pulmonary disease. Value in Health.
Voorham, J., Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., et al. (2018). Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022051
